Bailard, Inc. Kronos Bio, Inc. Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$1.24 - $1.92 $124 - $192	-100 Reduced 0.36%	27,600 $47,000
Q1 2023 May 08, 2023	BUY	$1.34 - $2.62 $37,118 - $72,574	27,700 New	27,700 $40,000
Q4 2021 Feb 10, 2022	SELL	$11.35 - $21.18 $601,550 - $1.12 Million	-53,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $49,059 - $66,690	2,700 Added 5.37%	53,000 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$20.08 - $29.02 $387,543 - $560,086	19,300 Added 62.26%	50,300 $1.21 Million
Q1 2021 May 13, 2021	BUY	$27.0 - $32.48 $837,000 - $1.01 Million	31,000 New	31,000 $907,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.